Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
deals
life sciences
4
×
national blog main
national top stories
4
×
new york blog main
new york top stories
boston blog main
boston top stories
novartis
startups
wisconsin blog main
wisconsin top stories
abbvie
alzheimer's disease
amgen
biotech
boulder/denver blog main
boulder/denver top stories
cystic fibrosis
detroit blog main
detroit top stories
diagnostics
fda
gene therapy
gilead sciences
indiana blog main
indiana top stories
merck
national
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
spark therapeutics
texas blog main
What
biggest
4
×
acquisitions
bio
ceo
deal
drug
roundup
age
albert
appear
bigger
bourla
build
buy
come
companies
company
company’s
crispr
daniel
debut
deerfield
didn't
dyne’s
emerging
end
eyeing
future
gave
gene
gilead
happening
imports
investment
involved
j
johnson
maker
maps
measured
Language
unknown
unset
Current search:
biggest
×
photo
×
" life sciences "
×
" national top stories "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
@xconomy.com
5 years ago
After Deal Stalled, Shine Medical Eyeing Up to $160M from Deerfield